The Bio-Diversity and the Role of Gut Microbiota in Postmenopausal Women with Luminal Breast Cancer Treated with Aromatase Inhibitors: An Observational Cohort Study

The interactions between aromatase inhibitors (AI) in breast cancer (BC) and gut microbiota (GM) have not been completely established yet. The aim of the study is to evaluate the bio-diversity of GM and the relationship between GM, inflammation and tumor-infiltrating lymphocytes (TILs) in postmenopa...

Πλήρης περιγραφή

Λεπτομέρειες βιβλιογραφικής εγγραφής

Κύριοι συγγραφείς:	Angioletta Lasagna, Mara De Amici, Chiara Rossi, Valentina Zuccaro, Marta Corbella, Greta Petazzoni, Francesco Comandatore, Lucia Sacchi, Giorgia Testa, Elisa Ferraris, Gianpiero Rizzo, Richard Tancredi, Alessandra Ferrari, Marco Lucioni, Paolo Sacchi, Raffaele Bruno, Paolo Pedrazzoli
Μορφή:	Artigo
Γλώσσα:	Inglês
Έκδοση:	MDPI AG 2022-11-01
Σειρά:	Pathogens
Θέματα:	estrobolome microbiome TILs breast cancer IL17 aromatase inhibitors
Διαθέσιμο Online:	https://www.mdpi.com/2076-0817/11/12/1421
Ετικέτες:	Προσθήκη ετικέτας Δεν υπάρχουν, Καταχωρήστε ετικέτα πρώτοι!